As 2026 approaches, the clinical research and development landscape is evolving beyond traditional scientific innovation with ...
Jubilant Therapeutics Inc., a clinical-stage biopharmaceutical company, has appointed Daniel J. O'Connor as President & Chief ...
The FDA has approved BMS’ Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed CAR T cell therapy, for adults with ...
Natera Inc., a cell-free DNA and precision medicine company, has acquired Foresight Diagnostics, a leader in ultrasensitive ...
CDMOs have become structural pillars of drug development, keeping pipelines moving, absorbing operational shocks, and turning ...
Neurimmune has expanded its transthyretin amyloid cardiomyopathy (ATTR-CM) collaboration with Alexion, an AstraZeneca company ...
BD said all configurations feature high-throughput automation and software designed for large dataset management and ...
Vetter, a globally leading CDMO, announced the retirement of its Managing Director, Thomas Otto, after over 35 years at the ...
Add capabilities in Europe and the U.S. for enhanced third-party logistics to support specialty pharmaceuticals.
Fresenius Kabi has introduced two new products in its Simplist portfolio of ready-to-administer prefilled syringes: Simplist ...
Regeneron Pharmaceuticals Inc. and Tessera Therapeutics Inc. have announced a global collaboration to develop and ...
Designed to improve analytical capabilities by separating particles prior to analysis, enabling high-resolution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback